Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase NA 8Phase 4 5Phase 3 5Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Vomiting 8Nausea 5Neoplasms 3Lymphoma 3Breast Neoplasms 3Leukemia 2Uterine Neoplasms 1Thyroid Neoplasms 1Sezary Syndrome 1Pruritus 1Post-Dural Puncture Headache 1Ovarian Neoplasms 1Hematologic Neoplasms 1

Interventions

Dexamethasone 5Aprepitant 5Palonosetron 3Ondansetron 3Granisetron 3Calcium Dobesilate 3Metoclopramide 2naldemedine 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1alizapride 1Tropisetron 1Tablets 1Duration of Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Nausea × Aprepitant × Clear all
NCT00588835 2020-11-30

ACE

Radboud University Medical Center

Phase 4 Terminated
20 enrolled

Nausea, Neoplasms

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed
494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT00092183 2017-05-05

An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

Merck Sharp & Dohme LLC

Phase 4 Completed
866 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

NCT01913990 2017-01-30

ER11-02

Ottawa Hospital Research Institute

Phase 4 Unknown
323 enrolled

Nausea, Vomiting

NCT00415103 2009-09-18

AMENO-2

PETHEMA Foundation

Phase 4 Completed
196 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡